FDA approves new drug to treat adults with community-acquired bacterial pneumonia

The U.S. Food and Drug Administration today approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia.
Read More


>>Hollywood's Exotic Secret For Healthy Weight Loss

0 Response to "FDA approves new drug to treat adults with community-acquired bacterial pneumonia"

Post a Comment